OXFORD, United Kingdom, April 17, 2023 (GLOBE NEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage biopharmaceutical company focused on the development of novel T cell immunotherapeutics ...
GEORGETOWN, GUYANA- February 2024-Guyana conducted the Human Papilloma Virus scientific conference on "Presenting the evidence on Cervical Cancer including HPV vaccination strategies to improve ...
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile The poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results